Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.

Kim, Myoung Jun

Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1. [electronic resource] - International journal of oncology Jul 2018 - 395-403 p. digital

Publication Type: Journal Article

1791-2423

10.3892/ijo.2018.4392 doi


Acetylation--drug effects
Apoptosis--drug effects
Carcinoma, Squamous Cell--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Esophageal Neoplasms--drug therapy
Esophageal Squamous Cell Carcinoma
Forkhead Box Protein O1--genetics
Gene Expression Regulation, Neoplastic--drug effects
Histone Deacetylase Inhibitors--pharmacology
Humans
Interleukin-7 Receptor alpha Subunit--genetics
Peptides, Cyclic--pharmacology